Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenretinide in Advanced Renal Cell Cancer
NCT00011973Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Dec 2000
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fenretinide in renal cell carcinoma (RCC), sponsored by Barbara Ann Karmanos Cancer Institute. Primary endpoint: Response Rate. Started Dec 2000; status: completed.
02
Drugs
fenretinide
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00011973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00011973.